Effect of hormone replacement therapy on cancer detection by mammography (multiple letters) [3]

Lancet

Volumn 349, Issue 9065, 1997, Pages 1624-1625

  Cohen, M E L ^a   Johnson, A ^a   Shekhdar, J ^a  

^a DERBY CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST CANCER; CANCER SCREENING; DENSITY; DIAGNOSTIC ACCURACY; DRUG WITHDRAWAL; EARLY DIAGNOSIS; FEMALE; GROWTH RATE; HORMONE SUBSTITUTION; HUMAN; LETTER; MAMMOGRAPHY; MENOPAUSE; ONSET AGE; PATIENT COMPLIANCE; PRIORITY JOURNAL; BREAST TUMOR; ESTROGEN THERAPY; MASS SCREENING; MIDDLE AGED; NOTE; PATHOLOGY; RADIOGRAPHY; TIME;

BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; TIME FACTORS;

EID: 0030952809     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)61662-5     Document Type: Letter

References (5)

1. V Beral E Banks G Reeves M Wallis Hormone replacement therapy and high incidence of breast cancer between screens Lancet 349 1997 1103 1104
2. AE Johnson J Shekhdar Interval cancers in the NHS Breast Screening Programme Br J Radiol 68 1995 862 869
3. AE Johnson MH Bennett CWD Cheung J Cox JELS Sales The management of individual breast cancers Breast 4 1995 100 111
4. CBJ Woodman AG Threlfall CRM Boggis P Prior Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region BMJ 310 1995 224 226
5. AG Threlfall CBJ Woodman P Prior Breast screening programme: should the interval between tests depend on age? Lancet 349 1997 472